Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”

Huang, Chung-Feng; Awad, Manar Hijaze; Gal-Tanamy, Meital; Yu, Ming-Lung

doi:.0..

Correspondence

Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”

Chung-Feng Huang^1,2,3, Manar Hijaze Awad⁴, Meital Gal-Tanamy⁴

, Ming-Lung Yu^1.2.5

¹Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital; College of Medicine and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan
²Faculty of Internal Medicine and Hepatitis Research Center, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
³Ph.D. Program in Translational Medicine, College of Medicine, Kaohsiung Medical University and Academia Sinica, Kaohsiung, Taiwan
⁴Molecular Virology Lab, The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
⁵School of Medicine and Doctoral Program of Clinical and Experimental Medicine, College of Medicine and Center of Excellence for Metabolic Associated Fatty Liver Disease, National Sun Yat-sen University, Kaohsiung, Taiwan

Correspondence :

Meital Gal-Tanamy ,
Tel: +972522959848, Fax: +972522959848, Email: Meital.Tanamy@biu.ac.il
Ming-Lung Yu ,
Tel: +886-7-3121101 ext.7475, Fax: +886-7-3234553, Email: fish6069@gmail.com

Received: June 24, 2024 Accepted: June 29, 2024
*Chung-Feng Huang and Manar Hijaze Awad contributed equally to this work.

KeyWords: HCV; DAA; SVR